Cresilon Inc. (Cresilon), a biotechnology company headquartered in Brooklyn and specializing in advanced hemostatic medical devices, has revealed a significant distribution partnership for its groundbreaking hemostatic gel, VETIGEL®, directly with Penn Veterinary Supply. This collaboration will offer veterinarians the opportunity to acquire VETIGEL® for treating animals. Penn Veterinary Supply is an independent regional distributor in the U.S., providing a range of veterinary products and services.
Cresilon’s VETIGEL® represents a remarkable breakthrough—a plant-based hemostatic gel that instantly halts and manages bleeding without requiring manual pressure. This innovative product is now accessible to veterinarians through Penn Veterinary Supply. Since its introduction in 2021, licensed veterinarians across the United States and the United Kingdom have been increasingly adopting VETIGEL® as their go-to hemostatic solution. It has proven highly effective in treating traumatic wounds and both routine and complex surgical procedures in animals, such as dental extractions, liver biopsies, tumor removals, cleft palate repairs, and amputations.
The availability of VETIGEL® through Penn Veterinary Supply marks a pivotal advancement.
Matt Lewis, Director of Veterinary Development and Sales at Cresilon, expressed, “Our collaboration with Penn Vet will expand the reach of our revolutionary hemostatic gel, enhancing the standard of care for pets and animals. VETIGEL® has garnered a strong following among veterinarians, showing its ability to accelerate patient healing and recovery while aiding veterinary clinics and animal hospitals in saving time, lowering operational expenses, and enhancing patient outcomes.”
Laura Williams, Director of Sales and Marketing at Penn Veterinary Supply, added, “We are thrilled to include VETIGEL® in our portfolio of hemostatic technologies. Collaborating with Cresilon, a company dedicated to introducing innovative products to the veterinary sector, aligns with our mission. VETIGEL® has the potential to significantly enhance patient outcomes, which benefits veterinarians and the animals they care for. We eagerly anticipate this partnership.”
VETIGEL® presents veterinarians with a reliable and efficient approach to controlling bleeding across various types of bleeds and diverse surgical procedures in Animal Health. This veterinary hemostatic agent comprises a hydrogel made from two plant-based polysaccharides. It promptly stops bleeding at the wound site, with the non-porous gel adhering without integrating into the robust fibrin patch. This instantaneous mechanical barrier halts bleeding on contact, all without the need for manual pressure, pre-preparation, or specific storage conditions.
Packaged in pre-filled syringes, this plant-based hemostatic gel is user-friendly and requires no special storage or preparation. For more details about VETIGEL®, please visit www.vetigel.com.
Cresilon® operates out of Brooklyn and specializes in designing, manufacturing, and marketing hemostatic medical devices utilizing its proprietary hydrogel technology. This plant-based technology has revolutionized bleeding control by halting traumatic and surgical bleeds within seconds, eliminating the need for manual pressure. Cresilon’s current and future product lines target veterinary, human trauma, and human surgical applications. The overarching mission of Cresilon is to save lives.
About Penn Vet
With a legacy spanning 40 years, Penn Veterinary Supply remains family-owned, with its roots tracing back to the original founder, Richard Sexton. Penn Vet is dedicated to serving the veterinary profession and extends pharmaceuticals, supplies, and equipment to veterinarians. The company is committed to offering services and solutions that empower independent, privately held veterinary hospitals.